| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3396127 | Antibiotiques | 2007 | 8 Pages |
Abstract
Gemifloxacin given once daily for as little as 5 days therapy has proven equivalent to, or superior to, comparator agents, it has an acceptable safely profile, and may be a cost-effective agent for lower respiratory tract infections.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
J.M. Blondeau, G. Tillotson,